Key facts
- Milvue’s last known valuation is $24.9M (Dec 2024).
- It has raised $19.7M; the latest was Later Stage VC ($10.5M) in Dec 2024.
- Notable investors include La French Tech, Daffourd Invest, EIT Health, French Tech Health20 Program, Guy Frija — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Milvue
- ·The full record, as it builds
Funding rounds
No funding rounds for Milvue are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Milvue
Developer of a medical imaging platform designed to enhance the reliability and efficiency of radiological diagnosis. The company's platform utilizes artificial intelligence for anomaly detection, real-time quantification, pre-reporting, and workflow prioritization, enabling physicians and medical specialists to improve accuracy, streamline processes, and reduce operational time.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2018
- Employees
- 32
- Website
- milvue.com/
- Ownership
- Privately Held (backing)
Milvue doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Milvue shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Milvue in its N-PORT filings yet. We sweep new filings monthly.